As of 2025-08-04, the Relative Valuation of Chinook Therapeutics Inc (KDNY) is (71.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.39 USD, the upside of Chinook Therapeutics Inc based on Relative Valuation is -276.0%.
The range of the Relative Valuation is (47.55) - (92.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 26.9x | 20.2x |
| Forward P/E multiples | 13.9x - 28.9x | 21.4x |
| Fair Price | (47.55) - (92.03) | (71.07) |
| Upside | -217.7% - -327.8% | -276.0% |
| Date | P/E |